Form 8-K - Current report:
SEC Accession No. 0001656472-24-000071
Filing Date
2024-05-28
Accepted
2024-05-28 17:02:27
Documents
14
Period of Report
2024-05-28
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K cron-20240528.htm   iXBRL 8-K 30374
2 EX-99.1 a240524staynersaleterminat.htm EX-99.1 8169
  Complete submission text file 0001656472-24-000071.txt   162211

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cron-20240528.xsd EX-101.SCH 1923
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cron-20240528_lab.xml EX-101.LAB 20678
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cron-20240528_pre.xml EX-101.PRE 11976
18 EXTRACTED XBRL INSTANCE DOCUMENT cron-20240528_htm.xml XML 2996
Mailing Address 111 PETER STREET SUITE 300 TORONTO A6 M5V 2H1
Business Address 111 PETER STREET SUITE 300 TORONTO A6 M5V 2H1 (416) 504-0004
Cronos Group Inc. (Filer) CIK: 0001656472 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38403 | Film No.: 24992885
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)